Provided are isotopologues of isoquinolinone and quinazolinone compounds of formula (AB′;) that modulate PI3 kinase activity, processes for the preparation of the compounds, pharmaceutical compositions comprising the compounds, and methods of treatment of diseases and disorders using the compounds or pharmaceutical compositions.